REQUEST A DEMO
Total
USD $0.00
Search more companies

Uranticorp S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Uranticorp S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Uranticorp S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Medical and Diagnostic Laboratories industry. It was established on October 05, 2009. 6 (2023) employees currently work for Uranticorp S.A.. There was a net sales revenue drop of 31.3% reported in Uranticorp S.A.’s latest financial highlights for 2023. There was a total growth of 10.43% in Uranticorp S.A.’s total assets over the same period. The enterprise’s net profit margin decreased by 3.4% in 2023.

Headquarters
Cordova 603, K1 Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Uranticorp S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Uranticorp S.A. report to view the information.
Outstanding Shares:
Purchase the Uranticorp S.A. report to view the information.
Registered Capital:
Purchase the Uranticorp S.A. report to view the information.
Incorporation Date:
October 05, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Uranticorp S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-31.3%
Total operating revenue
-31.3%
EBITDA
7.8%
Net Profit (Loss) for the Period
-84.66%
Total assets
10.43%
Total equity
-0.98%
Net Profit Margin
-3.4%
Return on Equity (ROE)
-12.47%
Quick Ratio
0.35%
Cash Ratio
-0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?